Funder
The National Key Research and Development Program of China
National Natural Science Foundation of China
SPDST | Sichuan Province Science and Technology Support Program
Fundarmental Research Funds for the Central Universities
1·3·5 Project for Disciplines of Excellence, West China Hospital, Sichuan University
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference43 articles.
1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers,2016
2. Targets for immunotherapy of liver cancer;Greten;J. Hepatol,2018
3. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009
4. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017
5. Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study;Johnson;J. Clin. Oncol,2013
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献